ACM
DVAX

AlphaCrest Capital Management’s Dynavax Technologies DVAX Stock Holding History

AlphaCrest Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-138,081
Closed -$1.5M – 1275
2022
Q1 		$1.5M Buy
138,081
+45,986
+50% +$559K 0.08% 364
2021
Q4 		$1.3M Buy
+92,095
New +$1.52M 0.05% 670
2019
Q3 		– Sell
-17,800
Closed -$71K – 1263
2019
Q2 		$71K Hold
17,800
– – 0.01% 998
2019
Q1 		$130K Buy
+17,800
New +$174K 0.02% 792

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

AlphaCrest Capital Management's DVAX Position: Q2 2022 in Review

AlphaCrest Capital Management sold out of Dynavax Technologies (DVAX) in Q2 2022, closing a stake of 138,081 shares — an estimated $1.5M sold.

AlphaCrest Capital Management first reported a position in DVAX in Q1 2019 and held it in 4 quarters. The position peaked at $1.5M in Q1 2022. 209 funds tracked by Wall St. Rank hold DVAX as of Q2 2022.

  • AlphaCrest Capital Management reported no remaining Dynavax Technologies position as of Q2 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 138,081 Dynavax Technologies shares in Q2 2022, an estimated $1.5M.
  • AlphaCrest Capital Management first reported a position in Dynavax Technologies in Q1 2019 and held it in 4 quarters.
  • AlphaCrest Capital Management's Dynavax Technologies position peaked at $1.5M in Q1 2022.
  • 209 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2022.

Based on AlphaCrest Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.